Dimensional Fund Advisors LP Sells 150,154 Shares of Tenet Healthcare Corporation $THC

Dimensional Fund Advisors LP lessened its position in Tenet Healthcare Corporation (NYSE:THC) by 10.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,332,083 shares of the company’s stock after selling 150,154 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.52% of Tenet Healthcare worth $270,447,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in THC. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare in the third quarter worth $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter valued at $35,000. Westside Investment Management Inc. lifted its position in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares in the last quarter. Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth about $41,000. Finally, True Wealth Design LLC grew its holdings in shares of Tenet Healthcare by 238.2% in the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company’s stock valued at $45,000 after acquiring an additional 181 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Stock Down 2.0%

Tenet Healthcare stock opened at $236.67 on Friday. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $247.21. The stock has a market cap of $20.58 billion, a P/E ratio of 15.28, a P/E/G ratio of 1.19 and a beta of 1.39. The company’s 50-day moving average price is $210.13 and its two-hundred day moving average price is $202.11. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 34,195 shares of company stock worth $7,912,606 in the last 90 days. Company insiders own 0.81% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a report on Monday, February 16th. KeyCorp boosted their price target on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, March 1st. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Finally, Jefferies Financial Group upped their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.